Skip to Content

SAGE Launches "Therapeutic Advances in Musculoskeletal Disease"

SAGE Launches Therapeutic Advances in Musculoskeletal Disease First issue available now

Los Angeles, London, New Delhi, Singapore and Washington DC (October 21, 2009) – SAGE is announcing the launch of Therapeutic Advances in Musculoskeletal Disease today, the latest in SAGE’s highly-regarded Therapeutic Advances series.

Therapeutic Advances in Musculoskeletal Disease is for all professionals concerned with research into, and the practice of, musculoskeletal disease and is a forum for all views on related subjects. The journal offers rapid peer-review and publication, with manuscripts published online within 7 weeks of acceptance. The editors welcome original research and review articles of latest advances in the treatment of arthropathies and other joint disorders, systemic connective tissue disorders, dorsopathies, soft tissue disorders, osteopathies and chondropathies.

Editor-in-Chief, Philip Sambrook OAM, has published over 270 peer reviewed papers including invited editorials in the New England Journal of Medicine, British Medical Journal and The Lancet. He is also the current President of the Australian & New Zealand Bone & Mineral Society, on the Committee of Scientific Advisors of The International Osteoporosis Foundation, and on the Board of the International Bone and Mineral Society.

“Musculoskeletal disease is affecting an increasing proportion of our aging population – the chronic diseases it includes have led to many new categories of medical treatments that are changing the way we manage patients,” said Philip Sambrook. “While there are many journals in this growing area, we still need to have more avenues to publish and access the material. For this reason, I am enthusiastic about leading the launch of this new journal.”

Therapeutic Advances in Musculoskeletal Disease is the seventh journal to be launched within the Therapeutic Advances series. Each publishes six issues per year and is freely available on the award-winning SAGE Journals Online platform for the first three years of publication.

“We’re delighted to be working with such a distinguished Editor-in-Chief and editorial board to continue the successful growth of the Therapeutic Advances series,” said Tessa Picknett, Publisher, STM journals. “Launching new journals continues to be challenging, but the impact that this series has made indicates there is still demand for access to timely peer-reviewed content in therapeutic treatments.”

For further information about Therapeutic Advances in Musculoskeletal Disease and to register for free access, visit<>.


SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC.<>

For more information, please contact: Mary Kay Jezzini SAGE Publicist 212-352-1404




Posted: October 2009